Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study

被引：13
|
作者：
Casale, Thomas B. [1 ]
Win, Patrick H. [2 ,3 ]
Bernstein, Jonathan A. [4 ,5 ]
Rosen, Karin [6 ]
Holden, Michael [6 ]
Iqbal, Ahmar [6 ]
Trzaskoma, Benjamin L. [6 ]
Yang, Ming [6 ]
Antonova, Evgeniya N. [6 ]
Murphy, Thomas [6 ,7 ]
Scarupa, Mark D. [8 ]
Sofen, Howard [9 ]
Kaplan, Allen [10 ]
机构：
[1] Univ S Florida, Tampa, FL USA
[2] Clin Res Ctr Southern Illinois, Shiloh, IL USA
[3] Washington Univ, Sch Med, St Louis, MO USA
[4] Bernstein Clin Res Ctr, Cincinnati, OH USA
[5] Univ Cincinnati, Cincinnati, OH USA
[6] Genentech Inc, San Francisco, CA 94080 USA
[7] Charleston ENT & Allergy, Charleston, SC USA
[8] Inst Asthma & Allergy, Chevy Chase, MD USA
[9] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
[10] Med Univ South Carolina, Charleston, SC USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2018年 / 78卷 / 04期
关键词：
DAILY DIARY;
D O I：
10.1016/j.jaad.2017.10.010
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：793 / 795
页数：3
相关论文
共 50 条
  • [1] The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria
    Maurer, Marcus
    Kaplan, Allen
    Rosen, Karin
    Holden, Michael
    Iqbal, Ahmar
    Trzaskoma, Benjamin L.
    Yang, Ming
    Casale, Thomas B.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (03) : 1138 - +
  • [2] Impact of omalizumab on patient-reported outcomes in chronic idiopathic urticaria: Results from a randomized study (XTEND-CIU)
    Casale, Thomas B.
    Murphy, Thomas R.
    Holden, Michael
    Rajput, Yamina
    Yoo, Bongin
    Bernstein, Jonathan A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (07): : 2487 - +
  • [3] Impact of Omalizumab Treatment Withdrawal After 24 and 48 Weeks in Patients with Chronic Idiopathic Urticaria: Results From the XTEND-CIU Study
    Kaplan, Allen P.
    Murphy, Thomas Robert
    Holden, Michael
    Iqbal, Ahmar
    Yoo, Bongin
    Bernstein, Jonathan A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB209 - AB209
  • [4] SUSTAINED IMPROVEMENT IN WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN CHRONIC SPONTANEOUS URTICARIA (CSU) PATIENTS WITH OMALIZUMAB: RESULTS FROM XTEND-CIU
    Maurer, M.
    Rajput, Y.
    Thomas, C.
    Holden, M.
    Yoo, B.
    [J]. VALUE IN HEALTH, 2018, 21 : S243 - S243
  • [5] The Urticaria Control Test as a Tool for Monitoring Chronic Idiopathic/Spontaneous Urticaria Treatment: Results From XTEND-CIU, a 48-Week, Randomized, Placebo-controlled Study
    Kaplan, Allen P.
    Casale, Thomas B.
    Bernstein, Jonathan A.
    Holden, Michael
    Iqbal, Ahmar
    Trzaskoma, Benjamin L.
    Maurer, Marcus
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB54 - AB54
  • [6] Effect of Anti-IgE (Omalizumab) in chronic idiopathic urticaria (CIU) patients
    Gober, L. M.
    Sterba, P. M.
    Eckman, J. A.
    Saini, S. S.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S147 - S147
  • [7] Efficacy of omalizumab treatment for patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU) in Taiwan
    Yan, Che-Wen
    Cho, Yung-Tsu
    Chu, Chia-Yu
    [J]. DERMATOLOGICA SINICA, 2017, 35 (04) : 182 - 186
  • [8] Successful treatment of chronic idiopathic urticaria & Angioedema (CIU), with Xolair (omalizumab)
    Shapiro, C. A.
    Kapetanos, N. S.
    Sarmiento, E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S274 - S274
  • [9] Study Design, Baseline and Open-Label Results from XTEND-CIU: A Phase IV, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Omalizumab through 48 Weeks in Patients with Chronic Idiopathic Urticaria
    Casale, Thomas B.
    Scarupa, Mark D.
    Holden, Michael
    Trzaskoma, Benjamin L.
    Antonova, Evgeniya
    Win, Patrick H.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB271 - AB271
  • [10] Omalizumab effectively reduces angioedema episodes in patients with chronic idiopathic/spontaneous urticaria (CIU/CSU)
    Staubach, P.
    Metz, M.
    Chapman-Rothe, N.
    Sieder, C.
    Braeutigam, M.
    Canvin, J.
    Maurer, M.
    [J]. EXPERIMENTAL DERMATOLOGY, 2016, 25 : 18 - 18
12345